Alfredo Falcone

41.5k citations

613 papers · 18.9k indexed · 8 hit papers · h-index 63

Impact in

Oncology top 0.05%
- Colorectal Cancer Treatments and Studies
- Cancer Treatment and Pharmacology
- Pancreatic and Hepatic Oncology Research
Hepatology top 0.1%
- Hepatocellular Carcinoma Treatment and Prognosis

Papers in

Oncology 475
- Colorectal Cancer Treatments and Studies 358
- Cancer Treatment and Pharmacology 184
- Pancreatic and Hepatic Oncology Research 60
Hepatology 86
- Hepatocellular Carcinoma Treatment and Prognosis 86

Co-authors: Fotios Loupakis Gianluca Masi Chiara Cremolini Giacomo Allegrini Romano Danesi Lisa Salvatore Giuseppe Tonini Heinz‐Josef Lenz
Journals: Journal of Clinical Oncology (151 papers)Annals of Oncology (104 papers)British Journal of Cancer (24 papers)European Journal of Cancer (21 papers)Clinical Colorectal Cancer (11 papers)
Partner nations: Italy United States Germany

In The Last Decade

Alfredo Falcone

586 papers receiving 18.5k citations

Hit Papers

8 papers align trajectories log scale

Drug-induced interstitial lung disease during cancer therapies: expert opinion on diagnosis and treatment 2022 · 130 citations

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if any of the following hold:

it has ≥500 total citations;
it reaches ≥1.5× the top-1% citation threshold for papers in the same subfield and year (the threshold is the minimum needed to enter the top 1%, not the average within it);
it reaches the top citation threshold in at least one of its specific research topics.

2022 ESMO Open
2019 Nature Genetics
2016 The Lancet Oncology
2015 JNCI Journal of the National Cancer Institute
2015 The Lancet Oncology
2014 New England Journal of Medicine
2012 The Lancet
2007 Journal of Clinical Oncology

Peers

Countries citing papers authored by Alfredo Falcone

Since Specialization

Citations

This map shows the geographic impact of Alfredo Falcone's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alfredo Falcone with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alfredo Falcone more than expected).

Fields of papers citing papers by Alfredo Falcone

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alfredo Falcone. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alfredo Falcone. The network helps show where Alfredo Falcone may publish in the future.

Co-authors

The 25 scholars most cited alongside Alfredo Falcone, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Alfredo Falcone Line = papers co-authored together Alfredo Falcone links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	First-line trifluridine/tipiracil + bevacizumab in patients with unresectable metastatic colorectal cancer: final survival analysis in the TASCO1 study British Journal of Cancer ·Eric Van Cutsem, Iwona Danielewicz, Mark Saunders, Per Pfeiffer, Guillem Argilés, Christophe Borg, Rob Glynne‐Jones, Cornelis J.A. Punt, Agnès J. van de Wouw, М. Yu. Fedyanin, Daniil Stroyakovskiy, Hendrik Kroening, Pilar García‐Alfonso, Harpreet Wasan, Alfredo Falcone, Ronan Fougeray, Anton Egorov, Nadia Amellal, Vladimir Moiseyenko	2022	9
2	Italian Results of the PRECONNECT Study: Safety and Efficacy of Trifluridine/tipiracil in Metastatic Colorectal Cancer Future Oncology ·Alberto Zaniboni, Carlo Barone, Maria Banzi, Francesca Bergamo, Livio Blasi, Roberto Bordonaro, Maria Di Bartolomeo, Francesco Di Costanzo, Giovanni Luca Frassineti, Carlo Garufi, Francesco Giuliani, Tiziana Pia Latiano, Erika Martinelli, Nicola Personeni, Patrizia Racca, Emiliano Tamburini, Giuseppe Tonini, Marie Georges Besse, Mario Spione, Alfredo Falcone	2021	6
3	RNA-Binding Protein Polymorphisms as Novel Biomarkers to Predict Outcomes of Metastatic Colorectal Cancer: A Meta-analysis from TRIBE, FIRE-3, and MAVERICC Molecular Cancer Therapeutics ·Hiroyuki Arai, Shu Cao, Francesca Battaglin, Jingyuan Wang, Natsuko Kawanishi, Ryuma Tokunaga, Fotios Loupakis, Sebastian Stintzing, Shivani Soni, Wu Zhang, Christoph Mancao, Bodour Salhia, Shannon M. Mumenthaler, Chiara Cremolini, Volker Heinemann, Alfredo Falcone, Joshua Millstein, Heinz‐Josef Lenz	2021	0
4	Triplet chemotherapy in combination with anti-EGFR agents for the treatment of metastatic colorectal cancer: Current evidence, advances, and future perspectives Cancer Treatment Reviews ·Gunnar Folprecht, Erika Martinelli, Thibault Mazard, Dominik Paul Modest, Akihito Tsuji, Regina Esser, Chiara Cremolini, Alfredo Falcone	2021	13
5	Zebrafish Patient-Derived Xenografts Identify Chemo-Response in Pancreatic Ductal Adenocarcinoma Patients Cancers ·Alice Usai, Gregorio Di Franco, Margherita Piccardi, Perla Cateni, Luca Emanuele Pollina, Caterina Vivaldi, Enrico Vasile, Niccola Funel, Matteo Palmeri, Luciana Dente, Alfredo Falcone, Dimitri Giunchi, Alessandro Massolo, Vittoria Raffa, Luca Morelli	2021	13
6	Role of Baseline Computed-Tomography-Evaluated Body Composition in Predicting Outcome and Toxicity from First-Line Therapy in Advanced Gastric Cancer Patients Journal of Clinical Medicine ·Silvia Catanese, Giacomo Aringhieri, Caterina Vivaldi, Francesca Salani, Saverio Vitali, Irene Pecora, Valentina Massa, Monica Lencioni, Enrico Vasile, Rachele Tintori, F. Balducci, Alfredo Falcone, Carla Cappelli, Lorenzo Fornaro	2021	15
7	Prognostic and Predictive Biomarkers in Patients with Metastatic Colorectal Cancer Receiving Regorafenib Molecular Cancer Therapeutics ·Yingmiao Liu, Jing Lyu, Kirsten B. Burdett, Alexander B. Sibley, Ace J. Hatch, Mark D. Starr, John C. Brady, Kelli Hammond, Federica Marmorino, Daniele Rossini, Richard M. Goldberg, Alfredo Falcone, Chiara Cremolini, Kouros Owzar, Anastasia Ivanova, Dominic T. Moore, Michael S. Lee, Hanna K. Sanoff, Federico Innocenti, Andrew B. Nixon	2020	15
8	Clinical Validation of a Machine-learning–derived Signature Predictive of Outcomes from First-line Oxaliplatin-based Chemotherapy in Advanced Colorectal Cancer Clinical Cancer Research ·Jim Abraham, Daniel Magee, Chiara Cremolini, Carlotta Antoniotti, David D. Halbert, Joanne Xiu, Phillip Stafford, Donald A. Berry, Matthew J. Oberley, Anthony F. Shields, John L. Marshall, Mohamed E. Salem, Alfredo Falcone, Axel Grothey, Michael J. Hall, Alan P. Venook, Heinz‐Josef Lenz, Anthony Helmstetter, W. Michael Korn, David Spetzler	2020	35
9	Immunogenic cell death pathway polymorphisms for predicting oxaliplatin efficacy in metastatic colorectal cancer Journal for ImmunoTherapy of Cancer ·Hiroyuki Arai, Yi Xiao, Fotios Loupakis, Natsuko Kawanishi, Jingyuan Wang, Francesca Battaglin, Shivani Soni, Wu Zhang, Christoph Mancao, Bodour Salhia, Shannon M. Mumenthaler, Daniel J. Weisenberger, Gangning Liang, Chiara Cremolini, Alfredo Falcone, Joshua Millstein, Heinz‐Josef Lenz	2020	27
10	A Model of a Zebrafish Avatar for Co-Clinical Trials Cancers ·Alice Usai, Gregorio Di Franco, Patrizia Colucci, Luca Emanuele Pollina, Enrico Vasile, Niccola Funel, Matteo Palmeri, Luciana Dente, Alfredo Falcone, Luca Morelli, Vittoria Raffa	2020	43
11	Early modifications of circulating microRNAs levels in metastatic colorectal cancer patients treated with regorafenib The Pharmacogenomics Journal ·Marta Schirripa, Beatrice Borelli, Romina D’Aurizio, Simone Lubrano, Chiara Cremolini, Gemma Zucchelli, Carlotta Antoniotti, Federica Marmorino, Alessandra Anna Prete, Sabina Murgioni, Francesca Bergamo, Vittorina Zagonel, Andrea Tuccoli, Andrea Marranci, Milena Rizzo, Lorena Tedeschi, Letizia Magnoni, Alfredo Falcone, Fotios Loupakis, Laura Poliseno	2019	5
12	A Polymorphism within the Vitamin D Transporter Gene Predicts Outcome in Metastatic Colorectal Cancer Patients Treated with FOLFIRI/Bevacizumab or FOLFIRI/Cetuximab Clinical Cancer Research ·Martin D. Berger, Sebastian Stintzing, Volker Heinemann, Shu Cao, Dongyun Yang, Yu Sunakawa, Satoshi Matsusaka, Yan Ning, Satoshi Okazaki, Yuji Miyamoto, Mitsukuni Suenaga, Marta Schirripa, Diana L. Hanna, Shivani Soni, Alberto Puccini, Wu Zhang, Chiara Cremolini, Alfredo Falcone, Fotios Loupakis, Heinz‐Josef Lenz	2017	21
13	Treatment with Antiangiogenic Drugs in Multiple Lines in Patients with Metastatic Colorectal Cancer: Meta-Analysis of Randomized Trials Gastroenterology Research and Practice ·Ralf‐Dieter Hofheinz, Ulrich Ronellenfitsch, Stefan Kubicka, Alfredo Falcone, Iris Burkholder, Ulrich Hacker	2016	9
14	Polymorphisms in Genes Involved in EGFR Turnover Are Predictive for Cetuximab Efficacy in Colorectal Cancer Molecular Cancer Therapeutics ·Sebastian Stintzing, Wu Zhang, Volker Heinemann, Daniel Neureiter, Ralf Kemmerling, Thomas Kirchner, Andreas Jung, Matthias Folwaczny, Dongyun Yang, Yan Ning, Ana Sebio, Stefan Stremitzer, Yu Sunakawa, Satoshi Matsusaka, Shinichi Yamauchi, Fotios Loupakis, Chiara Cremolini, Alfredo Falcone, Heinz‐Josef Lenz	2015	5
15	Folfoxiri with or Without Bevacizumab (Bev) As First-Line Treatment of Metastatic Colorectal Cancer (Mcrc): a Propensity Score-Based Analysis Annals of Oncology ·Chiara Cremolini, Fotios Loupakis, Daniele Rossini, Gianluca Masi, Lisa Salvatore, C. Barbara, I. Brunetti, Carlotta Antoniotti, Cristina Granetto, Enrico Cortesi, S. Chiara, S. Vitello, Sara Lonardi, L. Ciuffreda, Giovanni Tomasello, Monica Ronzoni, Angela Buonadonna, Daniela Tomčíková, Luca Boni, Alfredo Falcone	2014	2
16	Folfoxiri plus Bevacizumab as first-line treatment of BRAF mutant metastatic colorectal cancer patients. Annals of Oncology ·Lisa Salvatore, Fotios Loupakis, Chiara Cremolini, Marta Schirripa, Gianluca Masi, Carlotta Antoniotti, Lorenzo Fornaro, Elisa Sensi, Cristiana Lupi, Francesca Bergamo, Sara Lonardi, Zagonel, Gabriella Fontanini, Alfredo Falcone	2012	4
17	MicroRNA-21 in Pancreatic Cancer: Correlation with Clinical Outcome and Pharmacologic Aspects Underlying Its Role in the Modulation of Gemcitabine Activity Cancer Research ·Elisa Giovannetti, Niccola Funel, Godefridus J. Peters, Marco Del Chiaro, Leyla A. Erozenci, Enrico Vasile, Leticia G. León, Luca Emanuele Pollina, Annemieke Groen, Alfredo Falcone, Romano Danesi, Daniela Campani, Henk M.W. Verheul, Ugo Boggi	2010	376
18	Long-Term Outcome of Initially Unresectable Metastatic Colorectal Cancer Patients Treated with 5-Fluorouracil/Leucovorin, Oxaliplatin, and Irinotecan (FOLFOXIRI) Followed by Radical Surgery of Metastases Annals of Surgery ·Gianluca Masi, Fotios Loupakis, Luca Emanuele Pollina, Enrico Vasile, Samanta Cupini, Sergio Ricci, I. Brunetti, Roberta Ferraldeschi, Giuseppe Naso, Franco Filipponi, Andrea Pietrabissa, Orlando Goletti, Giacomo Giulio Baldi, Lorenzo Fornaro, M. Andreuccetti, Alfredo Falcone	2009	165
19	Treatment of metastatic renal cell carcinomawith constant-rate floxuridine infusion plus recombinant alpha 2b-interferon Annals of Oncology ·Alfredo Falcone, Claudia Cianci, E. Pfanner, Serafino Ricci, Monica Lencioni, I. Brunetti, P. C. Giulianotti, Luca Vannucci, Franco Mosca, Pierfranco Conté	1996	1
20	Tumor targeting by intra-arterial infusion of 5-[123I]Iodo-2' Deoxyuridine in patients with liver metastases from colorectal cancer. European Association of Nuclear Medicine Congress European Journal of Nuclear Medicine and Molecular Imaging ·Giuliano Mariani, Silvia Sacco, Francesco Matteucci, Duccio Volterrani, Janina Baranowska‐Kortylewicz, Rita Di Stefano, Stefano Ricci, C Bellina, Laura Troiani, L Di Luca, Alfredo Falcone, Piero Salvadori, Pierfranco Conté, A Sicari, Franco Mosca, S Aldestein, A.I. Kassis	1993	4

About Alfredo Falcone

Alfredo Falcone is a scholar working on Oncology, Hepatology, Cancer Research, Pulmonary and Respiratory Medicine and Pathology and Forensic Medicine, having authored 613 papers that have together received 18.9k indexed citations. Recurring topics across this work include Colorectal Cancer Treatments and Studies (358 papers), Cancer Treatment and Pharmacology (184 papers), Gastric Cancer Management and Outcomes (118 papers), Lung Cancer Treatments and Mutations (103 papers), Hepatocellular Carcinoma Treatment and Prognosis (86 papers), Cancer Genomics and Diagnostics (78 papers), Genetic factors in colorectal cancer (68 papers) and Pancreatic and Hepatic Oncology Research (60 papers). The work is most often cited by research in Oncology (13.6k citations), Hepatology (3.7k citations), Cancer Research (3.8k citations), Pathology and Forensic Medicine (3.4k citations) and Pulmonary and Respiratory Medicine (5.8k citations). Alfredo Falcone has collaborated with scholars based in Italy, United States and Germany. Frequent co-authors include Fotios Loupakis, Gianluca Masi, Chiara Cremolini, Giacomo Allegrini, Romano Danesi, Lisa Salvatore, Giuseppe Tonini, Heinz‐Josef Lenz, Enrico Vasile and Salvatore Siena. Their work appears in journals such as Journal of Clinical Oncology, Annals of Oncology, British Journal of Cancer, European Journal of Cancer and Clinical Colorectal Cancer.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact